ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2344

Transcriptional Regulation of Garp Expression

Sonja Haupt1, Qihui Zhou1, Johannes Thomas Kreuzer1, Simon Herrmann1, Hendrik Schulze-Koops1 and Alla Skapenko2, 1Division of Rheumatology and Clinical Immunology, Med.Klinik und Poliklinik IV, University of Munich, Munich, Germany, 2Division of Rheumatology and Clinical Immunology, University of Munich, Munich, Germany

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: glycoproteins, regulatory cells and rheumatoid arthritis (RA), T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: T-cell Biology and Targets in Autoimmune Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose: Regulatory T cells (Tregs) contribute to immune tolerance and play a pivotal role in the prevention of autoimmune diseases such as rheumatoid arthritis (RA). In active RA, the suppressive function of Tregs is markedly reduced. Recently, a membrane-associated molecule, glycoprotein A repetitions predominant (GARP), has been identified to be specifically expressed on Tregs in response to activation. While the function of GARP is not completely understood, diminution of GARP expression attenuates the suppressive capacity of Tregs. Therefore, we hypothesized that diminished expression of GARP on the surface of Tregs in RA patients might be responsible for their reduced suppressive function. To provide insight, we investigated in detail the molecular mechanisms of GARP transcription and analyzed GARP expression on Tregs from RA patients.

Methods: To delineate transcriptional mechanisms of GARP expression, human GARP promoter sequences and several CNS regions were cloned into reporter vectors. Their transcriptional activity in response to different stimuli was assessed. To analyze the chromatin configuration state in primary Tregs, chromatin immunoprecipitation of GARP promoters and CNS regions in activated and non-activated Tregs was performed. In order to investigate GARP expression, CD25+ and CD25– CD4 T cells were purified from peripheral blood, and GARP expression was compared between eight RA patients with early active disease (disease duration 3.0±2.4 months, DAS28 5.2±1.2) and an age- and gender-matched healthy cohort.

Results: Two different transcript variants under the control of different promoters (denoted as promoter 1 and 2) are encoded by the GARP gene. Whereas GARP promoter 1 activity was dependent on TCR stimulation and the presence of Forkhead box protein 3 (Foxp3), the master transcription factor of Tregs, Foxp3 and retinoic acid synergistically induced transcription from GARP promoter 2 in a concentration dependent manner. Histone modifications in both promoter regions and in an upstream located CNS changed towards a more accessible chromatin configuration upon T cell activation. When GARP expression was analyzed in primary T cells, only CD25+ Foxp3-expressing CD4 T cells upregulated GARP, confirming Treg specificity of GARP expression and its Foxp3 dependency. The upregulation of GARP expression upon stimulation was however less pronounced on Tregs from RA patients as compared to healthy controls.

Conclusion: Thus, GARP expression is attenuated in RA patients. As transcriptional activity of the GARP gene is initiated by coordinate action of TCR stimulation, Foxp3 and retinoic acid on two promoters and one CNS region, alterations of these control mechanisms in RA might cause diminished GARP expression and subsequently might result in the reduced suppressive capacity of Tregs in RA.


Disclosure:

S. Haupt,
None;

Q. Zhou,
None;

J. T. Kreuzer,
None;

S. Herrmann,
None;

H. Schulze-Koops,
None;

A. Skapenko,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/transcriptional-regulation-of-garp-expression/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology